Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis.

The adoption of an open-access tool validated by the research community, with clear parameter specification and standardized output, could greatly reduce heterogeneity in CDP estimation and promote repeatability of study results.